专题：Health Systems, Economic Evaluations, Quality of Life

This cluster of papers focuses on the intersection of health economics and quality of life assessment, with a particular emphasis on cost-effectiveness analysis, health utility measures such as EQ-5D and SF-36, quality-adjusted life years (QALY), health technology assessment, and preference-based measures for evaluating the economic impact of healthcare interventions.
最新文献
近5年高被引文献
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

article Full Text OpenAlex 5138 FWCI635.1101

2023 Alzheimer's disease facts and figures

article Full Text OpenAlex 3099 FWCI605.1348

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 2498 FWCI1224.3543

American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults

article Full Text OpenAlex 1310 FWCI210.9758

Multimorbidity

review Full Text OpenAlex 1303 FWCI174.4948

Chronic kidney disease and the global public health agenda: an international consensus

review Full Text OpenAlex 1121 FWCI846.4869

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

article Full Text OpenAlex 1024 FWCI239.3371

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

review Full Text OpenAlex 993 FWCI228.3945

The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice

article Full Text OpenAlex 959 FWCI973.8614

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 944 FWCI462.0112